
Adial Pharmaceuticals, Inc. (ADIL) - Yahoo Finance
Find the latest Adial Pharmaceuticals, Inc. (ADIL) stock quote, history, news and other vital information to help you with your stock trading and investing.
ADIL Stock Price | Adial Pharmaceuticals Inc. Stock Quote (U.S.: …
3 days ago · ADIL | Complete Adial Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Adial Pharmaceuticals (ADIL) Stock Price & Overview
2 days ago · A detailed overview of Adial Pharmaceuticals, Inc. (ADIL) stock, including real-time price, chart, key statistics, news, and more.
Home - Adial Pharmaceuticals Inc.
Nov 26, 2025 · Adial is a clinical-stage biopharmaceutical company focused on the treatment and prevention of addictions and other unmet medical needs.
ADIL: Adial Pharmaceuticals Inc - Stock Price, Quote and News - CNBC
Get Adial Pharmaceuticals Inc (ADIL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
ADIL $0.23 ( 3.05%) Adial Pharmaceuticals Inc | Google Finance
Get the latest Adial Pharmaceuticals Inc (ADIL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Adial Pharmaceuticals (ADIL) Stock Forecast & Price Target
Jan 9, 2026 · ADIL's current price target is $1.50. Learn why top analysts are making this stock forecast for Adial Pharmaceuticals at MarketBeat.
ADIL Stock Price Quote | Morningstar
4 days ago · See the latest Adial Pharmaceuticals Inc stock price (ADIL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
ADIL: Adial Pharmaceuticals Inc Latest Stock Price, Analysis, News …
Get real-time Adial Pharmaceuticals Inc (ADIL) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on …
ADIL | Adial Pharmaceuticals Inc. Stock Overview (U.S.: Nasdaq ...
View real-time ADIL stock price and news, along with industry-best analysis.